AAAAAA

   
Results: 1-23 |
Results: 23
IFOSFAMIDE AND VINORELBINE - AN ACTIVE REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKINS-DISEASE
Authors: BONFANTE V VIVIANI S SANTORO A DEVIZZI L DIRUSSO A ZANINI M SONCINI F PARRA HS VALAGUSSA P BONADONNA G
Citation: V. Bonfante et al., IFOSFAMIDE AND VINORELBINE - AN ACTIVE REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY HODGKINS-DISEASE, British Journal of Haematology, 103(2), 1998, pp. 533-535
SOLUBLE INTERLEUKIN-2 RECEPTORS (SIL-2R) IN HODGKINS-DISEASE - OUTCOME AND CLINICAL IMPLICATIONS
Authors: VIVIANI S CAMERINI E BONFANTE V SANTORO A BALZAROTTI M FORNIER M DEVIZZI L VERDERIO P VALAGUSSA P BONADONNA G
Citation: S. Viviani et al., SOLUBLE INTERLEUKIN-2 RECEPTORS (SIL-2R) IN HODGKINS-DISEASE - OUTCOME AND CLINICAL IMPLICATIONS, British Journal of Cancer, 77(6), 1998, pp. 992-997
SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME
Authors: NADALI G TAVECCHIA L ZANOLIN E BONFANTE V VIVIANI S CAMERINI E MUSTO P DIRENZO N CAROTENUTO M CHILOSI M KRAMPERA M PIZZOLO G
Citation: G. Nadali et al., SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME, Blood, 91(8), 1998, pp. 3011-3016
ACCEPTABILITY OF FOLLOW-UP VISITS (FU) IN LONG-TERM SURVIVORS FROM HODGKINS-DISEASE (HD)
Authors: MENCAGLIA E BONFANTE V VIVIANI S PARRA HS SANTORO A
Citation: E. Mencaglia et al., ACCEPTABILITY OF FOLLOW-UP VISITS (FU) IN LONG-TERM SURVIVORS FROM HODGKINS-DISEASE (HD), European journal of cancer, 33, 1997, pp. 266-266
4 CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD IRRADIATION (IF-RT) IS THE TREATMENT OF CHOICE FOR EARLY-STAGE HODGKINS-DISEASE (HD) - 5-YEAR RESULTS OF A RANDOMIZED TRIAL
Authors: SANTORO A BONFANTE V VIVIANI S ZANINI M DEVIZZI L PARRA HS DIRUSSO A SONCINI F VILLANI F VALAGUSSA P BONADONNA G
Citation: A. Santoro et al., 4 CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD IRRADIATION (IF-RT) IS THE TREATMENT OF CHOICE FOR EARLY-STAGE HODGKINS-DISEASE (HD) - 5-YEAR RESULTS OF A RANDOMIZED TRIAL, European journal of cancer, 33, 1997, pp. 1185-1185
INTERMEDIATE-HIGH DOSE SEQUENTIAL SINGLE-AGENT CHEMOTHERAPY COMBINED WITH IRRADIATION IN ADVANCED HODGKINS-DISEASE (HD)
Authors: BONFANTE V BONADONNA G SANTORO A VIVIANI S DEVIZZI L PARRA HS ZANINI M DIRUSSO A VILLANI F VALAGUSSA P
Citation: V. Bonfante et al., INTERMEDIATE-HIGH DOSE SEQUENTIAL SINGLE-AGENT CHEMOTHERAPY COMBINED WITH IRRADIATION IN ADVANCED HODGKINS-DISEASE (HD), European journal of cancer, 33, 1997, pp. 1194-1194
RELATION BETWEEN IL-10 AND IL-12 SECRETION IN HODGKINS-DISEASE (HD)
Authors: VIVIANI S NOTTI P BONFANTE V CAMERINI E PARRA HS SANTORO A
Citation: S. Viviani et al., RELATION BETWEEN IL-10 AND IL-12 SECRETION IN HODGKINS-DISEASE (HD), European journal of cancer, 33, 1997, pp. 1225-1225
COMPARISON OF GALLIUM SCAN, COMPUTED-TOMOGRAPHY, AND MAGNETIC-RESONANCE IN PATIENTS WITH MEDIASTINAL HODGKINS-DISEASE
Authors: DEVIZZI L MAFFIOLI L BONFANTE V VIVIANI S BALZARINI L GASPARINI M VALAGUSSA P BOMBARDIERI E SANTORO A BONADONNA G
Citation: L. Devizzi et al., COMPARISON OF GALLIUM SCAN, COMPUTED-TOMOGRAPHY, AND MAGNETIC-RESONANCE IN PATIENTS WITH MEDIASTINAL HODGKINS-DISEASE, Annals of oncology, 8, 1997, pp. 53-56
HODGKINS-DISEASE FAILURES - INCORPORATING RADIOTHERAPY AND HIGH-DOSE TREATMENT - REPLY
Authors: BONFANTE V VIVIANI S BONADONNA G
Citation: V. Bonfante et al., HODGKINS-DISEASE FAILURES - INCORPORATING RADIOTHERAPY AND HIGH-DOSE TREATMENT - REPLY, Journal of clinical oncology, 15(8), 1997, pp. 3023-3023
OUTCOME OF PATIENTS WITH HODGKINS-DISEASE FAILING AFTER PRIMARY MOPP-ABVD
Authors: BONFANTE V SANTORO A VIVIANI S DEVIZZI L BALZAROTTI M SONCINI F ZANINI M VALAGUSSA P BONADONNA G
Citation: V. Bonfante et al., OUTCOME OF PATIENTS WITH HODGKINS-DISEASE FAILING AFTER PRIMARY MOPP-ABVD, Journal of clinical oncology, 15(2), 1997, pp. 528-534
LATE PULMONARY TOXICITY AFTER TREATMENT FOR HODGKINS-DISEASE
Authors: VILLANI F DEMARIA P BONFANTE V VIVIANI S LAFFRANCHI A DELLOCA I DIRUSSO A ZANINI M
Citation: F. Villani et al., LATE PULMONARY TOXICITY AFTER TREATMENT FOR HODGKINS-DISEASE, Anticancer research, 17(6D), 1997, pp. 4739-4742
VINORELBINE - A NEW PROMISING DRUG IN HODGKINS-DISEASE
Authors: DEVIZZI L SANTORO A BONFANTE V VIVIANI S BONADONNA G
Citation: L. Devizzi et al., VINORELBINE - A NEW PROMISING DRUG IN HODGKINS-DISEASE, Leukemia & lymphoma, 22(5-6), 1996, pp. 409-414
LACK OF CARBOPLATIN ACTIVITY IN MALIGNANT-LYMPHOMAS
Authors: BALZAROTTI M TONDINI C BONFANTE V DEVIZZI L VIVIANI S FORNIER M SANTORO A
Citation: M. Balzarotti et al., LACK OF CARBOPLATIN ACTIVITY IN MALIGNANT-LYMPHOMAS, European journal of cancer, 32A(13), 1996, pp. 2370-2371
ALTERNATING VERSUS HYBRID MOPP AND ABVD COMBINATIONS IN ADVANCED HODGKINS-DISEASE - 10-YEAR RESULTS
Authors: VIVIANI S BONADONNA G SANTORO A BONFANTE V ZANINI M DEVIZZI L SONCINI F VALAGUSSA P
Citation: S. Viviani et al., ALTERNATING VERSUS HYBRID MOPP AND ABVD COMBINATIONS IN ADVANCED HODGKINS-DISEASE - 10-YEAR RESULTS, Journal of clinical oncology, 14(5), 1996, pp. 1421-1430
MEDICINE IN ITALY
Authors: VIVIANI S
Citation: S. Viviani, MEDICINE IN ITALY, Lancet, 348(9028), 1996, pp. 679-680
BRAZILIAN INDIANS UNMET HEALTH NEEDS
Authors: VIVIANI S
Citation: S. Viviani, BRAZILIAN INDIANS UNMET HEALTH NEEDS, Lancet, 347(9001), 1996, pp. 623-624
CLINICAL-SIGNIFICANCE OF SOLUBLE IL-2 RECEPTORS (S-IL-2R) IN HODGKINS-DISEASE (HD)
Authors: VIVIANI S DEVIZZI L BONFANTE V CAMERINI E SANTORO A FORNIER M VALAGUSSA P BONADONNA G
Citation: S. Viviani et al., CLINICAL-SIGNIFICANCE OF SOLUBLE IL-2 RECEPTORS (S-IL-2R) IN HODGKINS-DISEASE (HD), European journal of cancer, 31A, 1995, pp. 782-782
MULTIPLE DEFECTS OF T-HELPER CELL-FUNCTION IN NEWLY-DIAGNOSED PATIENTS WITH HODGKINS-DISEASE
Authors: CLERICI M FERRARIO E TRABATTONI D VIVIANI S BONFANTI V VENZON DJ CLERICI E SHEARER GM VILLA ML
Citation: M. Clerici et al., MULTIPLE DEFECTS OF T-HELPER CELL-FUNCTION IN NEWLY-DIAGNOSED PATIENTS WITH HODGKINS-DISEASE, European journal of cancer, 30A(10), 1994, pp. 1464-1470
MULTIPLE DEFECTS OF T-HELPER CELL-FUNCTION IN NEWLY-DIAGNOSED PATIENTS WITH HODGKINS-DISEASE
Authors: CLERICI M FERRARIO E TRABATTONI D VIVIANI S BONFANTI V VENZON DJ CLERICI E SHEARER GM VILLA ML
Citation: M. Clerici et al., MULTIPLE DEFECTS OF T-HELPER CELL-FUNCTION IN NEWLY-DIAGNOSED PATIENTS WITH HODGKINS-DISEASE, European journal of cancer, 30A(10), 1994, pp. 1464-1470
VINORELBINE - AN ACTIVE-DRUG FOR THE MANAGEMENT OF PATIENTS WITH HEAVILY PRETREATED HODGKINS-DISEASE
Authors: DEVIZZI L SANTORO A BONFANTE V VIVIANI S BALZARINI L VALAGUSSA P BONADONNA G
Citation: L. Devizzi et al., VINORELBINE - AN ACTIVE-DRUG FOR THE MANAGEMENT OF PATIENTS WITH HEAVILY PRETREATED HODGKINS-DISEASE, Annals of oncology, 5(9), 1994, pp. 817-820
CHILD SAFETY SEAT USE IN 7 ITALIAN REGION S
Authors: DARGENIO P BINKIN N CARRIERI MP SALAMINA G SALMASO S TAGGI F TOZZI A NICCOLINI A MAESTRO A CAFARO L LOMONACO R SODANO L PANDOLFI P FILIPPETTI F SELVAGGI TM VIVIANI S
Citation: P. Dargenio et al., CHILD SAFETY SEAT USE IN 7 ITALIAN REGION S, Rivista italiana di pediatria, 20(6), 1994, pp. 671-676
EXTENDED-FIELD RADIOTHERAPY IN FAVORABLE STAGE IA-IIA HODGKINS-DISEASE (PROGNOSTIC ROLE OF STAGE)
Authors: ZANINI M VIVIANI S SANTORO A SONCINI F BONFANTE V DEVIZZI L VILLANI F CASTELLANI MR NEGRETTI E ZUCALI R RILKE F BANFI A
Citation: M. Zanini et al., EXTENDED-FIELD RADIOTHERAPY IN FAVORABLE STAGE IA-IIA HODGKINS-DISEASE (PROGNOSTIC ROLE OF STAGE), International journal of radiation oncology, biology, physics, 30(4), 1994, pp. 813-819
CHILDHOOD VACCINATION COVERAGE IN ITALY - RESULTS OF A 7-REGION SURVEY
Authors: BINKIN N CARRIERI MP SALAMINA G SALMASO S TOZZI AE NICCOLINI A DARGENIO P MAESTRO AR CAFARO L LOMONACO R SODANO L PANDOLFI P FILIPPETTI F INCICCHITI L DERRICO MM SELVAGGI TM VIVIANI S
Citation: N. Binkin et al., CHILDHOOD VACCINATION COVERAGE IN ITALY - RESULTS OF A 7-REGION SURVEY, Bulletin of the World Health Organization, 72(6), 1994, pp. 885-895
Risultati: 1-23 |